Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.5K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Oncotarget·2018
Same author

Loss of miR-204 expression is a key event in melanoma.

Molecular cancer·2018
Same author

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Molecular and cellular biology·2018
Same author

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

Oncotarget·2018
Same author

Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.

Cancer letters·2018
Same author

The role of MicroRNAs in human cancer.

Signal transduction and targeted therapy·2017

Related Experiment Video

Updated: Apr 4, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

3.0K

miR-15b/16-2 deletion promotes B-cell malignancies.

Francesca Lovat1, Matteo Fassan2, Pierluigi Gasparini1

  • 1Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH 43210;

Proceedings of the National Academy of Sciences of the United States of America
|September 2, 2015
PubMed
Summary

The miR-15b/16-2 cluster loss in mice causes B-cell malignancy, similar to human chronic lymphocytic leukemia. This study reveals the cluster

Keywords:
B cellschronic lymphocytic leukemiamiR-15bmiRNAsmurine models

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.8K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.4K

Related Experiment Videos

Last Updated: Apr 4, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

3.0K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.8K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The miR-15a/16-1 microRNA cluster is crucial in B-cell cancers, with its deletion common in chronic lymphocytic leukemia (CLL).
  • The role of the related miR-15b/16-2 cluster in B-cell oncogenesis remains unclear, despite similarities to the well-studied miR-15a/16-1 cluster.

Purpose of the Study:

  • To investigate the in vivo biological role of the miR-15b/16-2 microRNA cluster in B-cell development and oncogenesis.
  • To determine if miR-15b/16-2 loss contributes to B-cell malignancies, particularly chronic lymphocytic leukemia.

Main Methods:

  • Generation of miR-15b/16-2 knockout mice to study the cluster's function in vivo.
  • Analysis of B-cell populations, spleen morphology, and disease progression in knockout mice.
  • Flow cytometry to identify specific B-cell populations (CD19+ CD5+).
  • Investigation of target genes modulated by miR-15b/16-2, including CCND2, CCND1, and IGF1R.

Main Results:

  • miR-15b/16-2 knockout mice developed B-cell malignancy with 60% penetrance by 15-18 months of age.
  • Affected mice exhibited enlarged spleens with abnormal B-cell white pulp.
  • A characteristic chronic lymphocytic leukemia-associated phenotype (expanded CD19+ CD5+ spleen population) was observed in 40% of knockout mice.
  • miR-15b/16-2 was found to modulate CCND2, CCND1, and IGF1R genes, which are critical for cell proliferation and survival.

Conclusions:

  • Loss of the miR-15b/16-2 cluster plays a significant role in the pathogenesis of B-cell chronic lymphocytic leukemia.
  • These findings highlight miR-15b/16-2 as a potential tumor suppressor in B-cell malignancies.
  • The study provides the first in vivo evidence linking miR-15b/16-2 dysregulation to B-cell cancer development.